Are you Dr. Powell?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 78 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-8964
Summary
- Dr. Jonathan Powell, MD is an oncologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland and Massachusetts. He is affiliated with Johns Hopkins Hospital and is an Associate Professor at Johns Hopkins University School of Medicine.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1995 - 1998
Johns Hopkins UniversityResidency, Internal Medicine, 1992 - 1995
Emory University School of MedicineClass of 1992
Certifications & Licensure
MD State Medical License 1996 - 2025
MA State Medical License 1995 - 2000
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2010
Publications & Presentations
PubMed
- 3 citationsMetabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder Cancers.Monali Praharaj, Fan Shen, Alex J Lee, Liang Zhao, Thomas R Nirschl
Cancer Immunology Research. 2024-07-02 - Adoptive transfer of CD49aTissue resident memory cells reverses pulmonary fibrosis in mice.Samuel L Collins, Yee Chan-Li, Kevin Shenderov, Astrid Gillich, Andrew M Nelson
Biorxiv. 2024-03-14 - SIKs Regulate HDAC7 Stabilization and Cytokine Recall in Late-Stage T Cell Effector Differentiation.Rachel S Helms, Alberto Marin-Gonzalez, Chirag H Patel, Im-Hong Sun, Jiayu Wen
Journal of Immunology. 2023-12-15
Press Mentions
GSK-Backed Biotech Gets $50M Upfront in Autoimmune Disease Deal with LillyMarch 31st, 2020
Another Immunometabolism Deal? Johns Hopkins Spinout Dracen Lands $36M Investment from DeerfieldMarch 22nd, 2018
Corvus Pharmaceuticals to Host R&D Day Highlighting the Role of the Adenosine Pathway in Immuno-OncologyMarch 9th, 2017- Join now to see all
